A carregar...
Implications of bevacizumab discontinuation in adults with recurrent glioblastoma
BACKGROUND: Patients with recurrent glioblastoma benefiting from bevacizumab are often treated indefinitely due to concerns regarding rebound tumor recurrence upon discontinuation. However, treatment is discontinued for reasons other than disease progression in a subset of these patients, the charac...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4022226/ https://ncbi.nlm.nih.gov/pubmed/24596117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|